Tokyo, Japan

Rina Nakamura

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rina Nakamura. Retrieved from https://idiyas.com/inventor/rina-nakamura-oe0q8dya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rina Nakamura: Innovator in Pharmaceutical Compounds

Introduction

Rina Nakamura is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. With a total of 2 patents, her work showcases her dedication to innovation and improvement in therapeutic agents.

Latest Patents

Nakamura's latest patents include a pyridone compound and a dibenzooxepin derivative. The pyridone compound is represented by a specific formula and is noted for its potential as a prophylactic and therapeutic agent for skin diseases. The dibenzooxepin derivative, on the other hand, is characterized by its PPARγ agonist activity, making it useful as a therapeutic and prophylactic agent for type 2 diabetes.

Career Highlights

Throughout her career, Rina Nakamura has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Nakamura has collaborated with esteemed colleagues, including Kimihisa Ueno and Seiji Aratake. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in healthcare.

Conclusion

Rina Nakamura's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a key innovator. Her work continues to impact the development of therapeutic agents, showcasing the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…